Dr. Suresh Ramalingam discussed how the LAURA findings support the role of Tagrisso as a backbone therapy across multiple settings in EGFR-mutated NSCLC.
Dr. Suresh S. Ramalingam
Advertisement
Dr. Suresh Ramalingam is a board-certified medical oncologist specializing in small cell and non-small cell lung cancer. He serves as executive director of Winship Cancer Institute of Emory University, as well as associate vice president for cancer of Woodruff Health Sciences Center, and holds the Roberto C. Goizueta Distinguished Chair for Cancer Research.
Articles by Dr. Suresh S. Ramalingam
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
